ULTRASITE
Report
- Report Number
- 2523676-2006-00114
- Event Type
- Other
- Date Received
- January 17, 2007
- Report Date
- January 8, 2006
- Manufacturer
- B. BRAUN MEDICAL, INC.
- Product Code
- FPA
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AL, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
THE ACTUAL DEVICES INVOLVED IN THE INCIDENTS WERE MADE AVAILABLE FOR THE MFR TO EVALUATE. A LOT NUMBER WAS NOT KNOWN. DIRECTIONS FOR USE ON THE ULTRASITE VALVE IFU STATES: USE ASEPTIC TECHNIQUE. SWAB INJECTION SITE PRIOR TO USE PER INSTITUTIONAL PROTOCOL. USE A LUER LOCK CONNECTOR WITHOUT A NEEDLE. FLUSH PER INSTITUTIONAL PROTOCOL USING SALINE ONLY OR SALINE WITH HEPARIN. REPLACE SET EVERY 24 HRS OR PER CDC GUIDELINES AND OR INSTITUTIONAL PROTOCOL. SEVERAL STUDIES HAVE BEEN CONDUCTED INDICATING NO INCREASE IN THE OCCURRENCE OF SEPSIS WITH THE USE OF ULTRASITE. ALL B. BRAUN STERILE PACKAGED LOTS ARE CERTIFIED AS STERILE PRIOR TO SHIPPING, AND THE APPROPRIATE RECORDS ARE KEPT ON FILE. SINCE A LOT NUMBER WAS NOT REPORTED LAL AND STERILITY TEST RESULTS COULD NOT BE REVIEWED FOR THIS INCIDENT. HOWEVER, ALL OUR STERILIZATION PROCESSES ARE VALIDATED AND MONITORED WITH BIOLOGICAL INDICATORS. IF PERTINENT INFO BECOMES AVAILABLE FROM THE FACILITY, A FOLLOW-UP REPORT WILL BE FILED. NO SPECIFIC CONCLUSIONS CAN BE DRAWN.
AS REPORTED BY THE REG MGR PER THE FACILITY. INCREASED INFECTION- ALMOST 2 STANDARD DEVIATIONS ABOVE THE UNIT MEAN RATE PRIOR TO USE ON CENTRAL LINES- OCTOBER RESULTS ON ONE MED SURG UNIT. ADDITIONAL INFO PROVIDED BY THE FACILITY INDICATED A TRIAL OF THE PRODUCT WAS BEING PERFORMED AND THE FACILITY NOTED AN INCREASE IN INFECTION RATE WHEN TRIALING THE PRODUCT. NO ADDITIONAL INFO WAS AVAILABLE ON THE STATUS OF ANY OF THE PTS. THE LOT NUMBER REMAINS UNK.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ULTRASITE | ULTRASITE VALVE | FPA | B. BRAUN MEDICAL, INC. | CSU100 | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | YR | Other |